| PE team member companies | Abbvie, Allergan, Amgen, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, EMD Serono/Merck Healthcare KGaA, GlaxoSmithKline, Janssen, Lilly, Merck, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, and UCB Pharma |
| SME roles |
Decision maker for study design (e.g., clinical science/ development leaders) Influencer responsible for study design and conduct (e.g., operational study team, biostatistics, and patient-reported outcomes [PRO] scientists) Strategic driver of patient centricity (e.g., corporate strategy executives, Chief Patient Officers, patient network and advisory leaders) Decision maker for operational plans (e.g., clinical operations leaders) Senior Stakeholder Engagement Manager Vice President Medical Science, Oncology Clinical Operations Lead; Global Program Lead; Innovation Head Individuals who conduct external patient engagement activities (e.g., advocacy groups) |
| Therapeutic areas | Anti-Infectives, BioMedicines, Bone, Cardiovascular, Central Nervous System, Dermatology, Devices, Diabetes, Endocrinology, Eye Care, Gastroenterology, Internal Medicine, Immunology, Immuno-oncology, Medical Aesthetics, Metabolism, Oncology, Respiratory, Urology, and Virology |